Methotrexate plus Bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck.
D000328:Adult; D000368:Aged; D001500:BCG Vaccine; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D007822:Laryngeal Neoplasms / Q000628:therapy; D008048:Lip Neoplasms / Q000628:therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009060:Mouth Floor; D009062:Mouth Neoplasms / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D014067:Tonsillar Neoplasms / Q000628:therapy
D001500:BCG Vaccine; D003520:Cyclophosphamide; D007538:Isoniazid; D008727:Methotrexate